Cataract in children after bone marrow transplantation: Relation to conditioning regimen

Acta Ophthalmologica Scandinavica

Volumn 80, Issue 2, 2002, Pages 211-215

  Holmström, Gerd ^a,b   Borgström, Birgit ^b   Calissendorff, Berit ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ST ERIK S EYE HOSPITAL   (Sweden)

Author keywords

Bone marrow transplantation (BMT); Busulphan (BU); Cataract; Total body irradiation (TBI)

Indexed keywords

BUSULFAN; CORTICOSTEROID; CYTOSTATIC AGENT; PREDNISOLONE;

ADOLESCENT; AMBLYOPIA; ARTICLE; BONE MARROW TRANSPLANTATION; CATARACT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; VISUAL SYSTEM EXAMINATION; WHOLE BODY RADIATION;

BONE MARROW TRANSPLANTATION; BUSULFAN; CATARACT; CATARACT EXTRACTION; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LENS, CRYSTALLINE; LEUKEMIA; MALE; PROSPECTIVE STUDIES; RADIATION INJURIES; TRANSPLANTATION CONDITIONING; WHOLE-BODY IRRADIATION;

EID: 0036121321     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2002.800217.x     Document Type: Article

References (28)

1. Cataract after busulphan therapy
2. Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis
3. Allogeneic bone marrow transplantation for acute myeloid leukaemia in first remission: A randomized trial of busulphan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen
4. A prospective randomized comparison of total body irradiation-ectoposide versus busulphan-cyclophosphamide as preparative regimens for bone marrow transplantation in patients with leukaemia who were not in first remission
5. Ocular complications of bone marrow transplantation
6. Cataract development and outcome of surgery in bone marrow transplanted children
7. The development of cataract in children as a late side-effect of bone marrow transplantation
8. Marrow transplantation for chronic myeloid leukaemia: A randomized study comparing cyclophosphamide and total body irradiation with busulphan and cyclophosphamide
9. The eye in bone marrow transplantation
10. Clinical and morphological side-effects of busulphan (Myleran) treatment
11. Cataracts after total body irradiation and marrow transplantation: A review of delayed complications
12. Long-term outcome after marrow transplantation for severe aplastic anaemia
13. Allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: A randomized trial of busulphan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen
14. Ocular toxicity of antineoplastic agents
15. Interference with cell proliferation and induction of polyploidy in rat lens epithelium during prolonged Myleran treatment
16. Ophthalmic evaluation of survivors of acute lymphoblastic leukaemia
17. Irradiation cataract in children after bone marrow transplantation
18. Additional observations on the effects of busulphan on cataract formation, duration of anaesthesia, and reproduction in rats
19. Ocular complications of bone marrow transplantation
20. Lens changes in chronic granulocytic leukaemia. Possible relationship to chemotherapy
21. Randomized study with cyclosporin in kidney transplantation: 10-year follow-up
22. Cataract after busulphan treatment
23. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopaecia with busulphan versus total body irradiation: Long-term results of a randomized trial in allogeneic marrow leukaemia
24. A randomized trial comparing busulphan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukaemia
25. The lens epithelium in the pathogenesis of cataract
26. Cataract after prolonged busulphan therapy
27. Cataract formation after bone marrow transplantation
28. Corticosteroid-induced cataracts